SUNITINIB MALATE AS MAINTENANCE THERAPY IN PATIENTS (PTS) WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY

被引：0

作者：

Blais, N. ^{[1
]}

Page, R. ^{[2
]}

Hainsworth, J. ^{[3
]}

Soria, J. ^{[4
]}

Laskin, J. ^{[5
]}

Hamm, J. T. ^{[6
]}

Selaru, P. ^{[7
]}

Kim, S. T. ^{[7
]}

Chao, R. ^{[7
]}

Gervais, R. ^{[8
]}

机构：

[1] CHUM Hop Notre Dame, Montreal, PQ, Canada

[2] Ctr Canc & Blood Disorders, Ft Worth, TX USA

[3] Sarah Cannon Res Inst, Nashville, TN USA

[4] Inst Gustave Roussy, Villejuif, France

[5] BC Canc Agcy, Vancouver, BC, Canada

[6] Norton Canc Inst, Louisville, KY USA

[7] Pfizer Inc, Global Res & Dev, La Jolla, CA USA

[8] Oncol Inst F Baclesse Ctr, Caen, France

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：109 / 109

页数：1

共 50 条

[41] Phase II clinical trial of kahalalide F (KF) as a second line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Provencio, Mariano
Izquierdo, Angel
Vinolas, Nuria
Paz-Ares, Luis
Feliu, Jaime
Constenla, Manuel
de las Heras, Begona
Erustes, Mercedes
Izquierdo, Miguel A.
Rosell, Rafael
ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
[42] A Phase II Study of Sorafenib in Patients with Locally Advanced And/or Metastatic (stage IIIB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras Mutation
Dingemans, A. M.
Mellema, W. W.
Groen, H. J. M.
van Wijk, A.
Burgers, S.
Kunst, P. W. A.
Thunnissen, F. B.
Heideman, D. A. M.
Smit, E. F.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : 14 - 14
[43] Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Arbour, Kathryn C.
Riely, Gregory J.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 764 - 774
[44] Concurrent chemoradiotherapy with Gemcitabine for locally advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
Athanasiou, E
Cyrgias, G
Boinis, K
Samantas, E
Christodoulidou, M
Tamvaki, F
Panoussaki, E
ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
[45] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
Aerts, Joachim G.
van Klaveren, Rob J.
Surmont, Veerle
Senan, Suresh
Tan, Yoeke
Vernhout, Rene
van Wijhe, Gerda
Verhoeven, Gert T.
Hoogsteden, Henk C.
van Meerbeeck, Jan P.
ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
[46] Phase II study of irinotecan and S-1 combination therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): (WJTOG3505)
Ishimoto, O.
Okamoto, I.
Nishimura, T.
Yoshioka, H.
Kubo, A.
Takeda, K.
Ebi, N.
Katakami, N.
Saka, H.
Fukuoka, M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[47] Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC).
Kubota, K.
Masuhara, H.
Hosoya, K.
Yoh, K.
Niho, S.
Goto, K.
Ohmatsu, H.
Nishiwaki, Y.
Saijo, N.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 392S - 392S
[48] BIOMARKER DEVELOPMENT FOR A PHASE II STUDY OF COMBINATION EPIGENETIC THERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Wrangle, John M.
Juergens, Rosalyn A.
Vendetti, Frank
Coleman, Barbara
Sebree, Rosa
Rudek, Michelle
Herman, James
Rudin, Charles
Brock, Malcolm V.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1101 - S1101
[49] PHYSICAL TARGETING OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PROTON THERAPY
Cox, James D.
Quynh Nguyen
Allen, Pamela
Ly, Ngoc B.
Gomez, Daniel
Chang, Joe
Liao, Zhongxing
Tsao, Anne
Komaki, Ritsuko
Lu, Charles
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S597 - S597
[50] Phase II trial of combined modality therapy (cmt) with myeloid growth factors in patients with locally advanced non-small cell lung cancer (NSCLC)
Lilenbaum, R.
Samuels, M.
Taffaro-Neskey, M.
Cusnir, M.
Pizzolato, J.
Blaustein, A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →